Olga Waln – Projects — Houston Methodist Scholars

View Scopus Profile

h-index

Research activity per year

1 Finished
1 Not started
6 Active

8 results

Active

Non-Invasive Brainstem Modulation for the Treatment of Non-Motor Symptoms in Parkinson?s Disease: A Randomized Controlled Trial (RCT) and an Open Label Extension (OLE) Study
Ondo, W. G., Billnitzer, A. & Waln, O.
10/1/22 → …
Project: Clinical Trial
Open Label Study of Pitolisant (Wakix) as Adjunct Therapy for Subjects with Refractory Restless Legs Syndrome
Ondo, W. G. & Waln, O.
9/15/22 → …
Project: Clinical Trial
A Phase 2b, 12-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study of the Safety and Efficacy of JZP385 in the Treatment of Adults with Moderate to Severe Essential Tremor
Waln, O. & Ondo, W. G.
8/8/22 → …
Project: Clinical Trial
CVL-751-PD-004 (TEMPO-1 TRIAL)
Ondo, W. G. & Waln, O.
5/11/21 → …
Project: Clinical Trial
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Two Fixed Doses of Tavapadon in Early Parkinson's Disease (TEMPO-1 TRIAL)
Ondo, W. G. & Waln, O.
8/6/20 → …
Project: Clinical Trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson's Disease
Ondo, W. G. & Waln, O.
10/22/19 → …
Project: Clinical Trial
Not started

A Double-Blind, Placebo-Controlled, Randomized, 18-Month Phase 2a Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral UCB0599 in Study Participants With Early Parkinson's Disease
Waln, O. & Ondo, W. G.
Project: Clinical Trial
Finished

A Randomized Placebo-controlled Trial of Zoledronic Acid for Prevention of Fractures in Patients with Parkinson¿s Disease
Waln, O. & Ondo, W. G.
7/14/21 → 7/13/23
Project: Non Profit